This top MSO just announced another big acquisition…

In 2012, Colorado voters rallied together to make a historic vote, passing Amendment 64.

That’s what kicked off adult-use cannabis sales.

Fast forward six years later and, in Denver, you’re more likely to find a cannabis dispensary than a Starbucks. We’re talking about 364 dispensaries compared to 80 Starbucks in the Mile High City in 2018.

All those storefronts equal big bucks.

After all, estimates show $1.6 billion in legal cannabis was sold in Colorado last year, which was second only to California‘s $3.1 billion in sales.

It’s an important market.

One that Curaleaf Holdings Inc. (OTC: CURLF) was missing out on.

Until its latest major acquisition, that is…

Curaleaf Enters $1.6 Billion Colorado Market

Curaleaf, a well-known multi-state operator (MSO), is building an impressive foothold across the United States.

Click to enlarge

Now, it will sell even more products than ever before with its acquisition of Colorado-based BlueKudu.

BlueKudu is an edibles company that has been offering premium products since 2011. It has chocolates, bonbons, and four flavors of gummies.

The best CEOs know that they need to be everywhere their customer is and, with full legalization on the horizon, that means building in more states now in anticipation of what is to come.

[ACT NOW]: Before federal legalization takes hold, find out which cannabis companies could deliver you the highest potential gains with the 2020 Pot Profits Roadmap.

This is all a part of Phase 2, where the largest companies will acquire small and specialty companies to expand and reach new customers. CEOs can either build or buy for growth.

Sometimes the best move to make is to buy.

With an established company like BlueKudu, it’s been in operation for eight years, has a foothold in the second-biggest cannabis marketing in America, and it has an established clientele that wants premium products, which can offer higher margins.

It could take years for Curaleaf to build something like that.

But with acquisitions, deals can finalize in months.

Mergers and acquisitions (M&A) have been fast and furious in 2020. Here’s a look at how they’re leading this year’s top cannabis trends.

Final Thoughts

Our discussion of Curaleaf today does not mean that we’re recommending the company.

Rather, its acquisition is an important signal of what’s happening in the cannabis industry.

One of the biggest MSOs in the country is still expanding, making a strategic move to reach even more customers than ever before.

That makes companies stronger, increases brand recognition, and leads to more revenue.

All of which is a clear sign that Phase 2 is fully underway.

Take care,


8 responses to “Curaleaf Is Betting Big on Denver With Its Latest Acquisition”

    • I’ve listened and bought almost all the pot stocks you recommended 15 months ago. All have 100 % our better return. Accept one Schwartz i bought 17,000 shares at 1.68 sold at 1.12 .recently I bought back 5000 shares at 2.40 I should have kept it all . I still believe in Schwartz hope they take off. And all this during these rough times. THANK GOD FOR WEED. BE SAFE Jack.M

  1. This is definitely the most comprehensive letter that I have seen on cannabis. Even-though, it is a challenge to over all of the cannabis stock: your definitely through with the entities that you cover. I am glad to be a part of this organization.

    • Hi Homer,

      These are the brokerage services a lot of our members have found easy to use:

      eTrade 1 (800) 387-2331
      Fidelity – 1 (800) 343-3548
      TDAmeritrade – 1 (800) 669-3900

      Robinhood is also very easy to use, but it does not have all of the cannabis stocks we trade.

Leave a Reply

Your email address will not be published. Required fields are marked *